Disease - Pipeline Review, H2 2015', provides an overview of the Gaucher's
Disease's therapeutic pipeline.
Gynecologic and obstetric aspects of Gaucher's
disease: a survey of 53 patients.
The Gaucher ' s Disease Pipeline Review, H2 2014 report provides comprehensive information on the therapeutic development for Gaucher's
Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Unusual expression of Gaucher's
disease: cardiovascular calcifications in three sibs homozygous for the D409H mutation.
Pulmonary hypertension in type 1 Gaucher's
disease: genetic and epigenetic determinants of phenotype and response to therapy.
In the new study, the researchers revealed how the widely available prescription drugs diltiazem, verapamil, and in some cases dantrolene, acted on cells from patients with Gaucher's
Upper limb involvement in patients with Gaucher's
Replacement therapy for inherited enzyme deficiency-macrophagetargeted glucocerebrosidase for Gaucher's
The recent arrival on the market of a modified glucocerebrosidase (Ceredase) for Gaucher's
Disease and last year's approval of PEG-adenosine deaminase for severe combined immunodeficiency disease illustrate the growing capabilities of the pharmaceutical industry to provide endogenous compounds that patients are lacking.
Brady first proposed enzyme-replacement therapy for Gaucher's
disease 25 years ago.
This report provides information on the therapeutic development for Gaucher's
Disease, complete with latest updates, and special features on late-stage and discontinued projects.
family on Tuesday, February 28, 2012 from 4-7 PM in the Britton-Shrewsbury Funeral Home, 648 Main Street, Shrewsbury.
disease, an inherited enzyme deficiency, affects more than 20,000 people in the United States and is especially prevalent among Jews of Eastern European ancestry.
Tiscornia's project is entitled "Development of an induced pluripotent stem cell model of neuronopathic Gaucher's
Disease for investigating mechanisms of pathogenesis and small molecule testing.
2) In photo above, Gaucher's
granddaughter Alexandra Smith, 6, center, plays games with her friend Cameryn Husson, 11, before the ceremony.